Terms and Conditions

Norethisterone Tablet

ByPharma Updates

Sep 10, 2020 , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Norethisterone Tablet

PURPOSE:  This Master formula record (MFR) is written to describe the formulae, manufacturing procedure, specifications, packing details of dosage form.

SCOPE: This MFR is performed and is applied during the manufacturing of dosage form.

RESPONSIBILITY / ACCOUNTABILITY: It is the responsibility of Manufacturing Chemist to follow and adhere to this SOP. The Production Pharmacist, QC/QA Manager are accountable for the strict adherence to the master formula.

COPY ISSUED TO:

Master Copy: Manager Quality Assurance

Copy No. 1: Production Pharmacist

Copy No. 2: Manager Quality Control

Copy No.  3:  Tablet Section

PRODUCT NAME: Norethisterone Tablet BATCH SIZE:  1.0 LACS
PRODUCT REFERENCE CODE:  UNIT SIZE:  1X30
GENERIC NAME: NORETHISTERONE TABLETS B.P. PACK SIZE:  39 X 10 X 1 X 30
DOSAGE FORM: TABLET STRENGTH: N.A.
DEPARTMENT:  TABLET DEPARTMENT EXPIRY DATE: AFTER 36 MONTHS FROM THE DATE OF MANUFACTURING

COMPOSITION:

Each Uncoated Tablet contains:

Norethisterone                B.P.                      5 mg

EQUIPMENTS TO BE USED:

SR. NO. NAME OF EQUIPMENT ASSEMBLING

AS PER SOP NO.

CLEANING

AS PER SOP NO.

1 Steam Jacketed Starch Paste Preparation Tank
2 Sifter Machine
3 Roto Cube Blender
4 Rapid Mixer Granulator
5 Multi Mill
6 Fluidized Bed Drier
7 Oscillating Granulator
8 Sifter Machine
9 Roto Cube Blender
10 Tablet Compression Machine 27 Stations
11 Dedusting Machine
12 Tablet Inspection Machine
13. Single Track Blister Machine

RAW MATERIAL: –

S.NO. INGREDIENTS STD Theoretical Quantity Req. Overages % Total Quantity Used
1. AEROSIL    B.P. 0.030 0.030 KG
2. DI CALCIUM PHOSPHATE B.P. 5.650 5.650 KG
3. LACTOSE B.P. 3.000 3.000 KG
4. MICRO CELLULOSE CRYSTALLINE PHOSPHATE B.P. 1.000 1.000 KG
5. MAGNESIUM STEARATE B.P. 0.200 0.200 KG
6. NORETHISTERONE B.P. 0.500 2.000 0.510 KG
7. SODIUM BENZOATE B.P. 0.030 0.030 KG
8. STARCH B.P. 10.200 10.200 KG
9. STARCH B.P. 0.600 0.600 KG
10. STARCH B.P. 0.800

 

0.800 KG
11. TALCUM B.P. 0.400 0.400 KG

 PACKING MATERIAL:-

S.NO. NAME OF THE MATERIAL Theoretical Quantity Req. For

Record

Total Quantity Used
1. 104 MM CLEAR PVC 9.000 9.000 KG
2. ADHESIVE TAPE ROLL BROWN 1.00 1.00 KGS
3. REGULATE-N ALUMINIUM FOIL 2.000 2.000 KGS
4 UNIT CARTON 3333.333 2.00 3335.333 NOS
5 SHRINK FILM 220X220 MM 333.334 333.334 NOS
6 CORRUGATED BOX D-17 8.547 8.547 NOS

MANUFACTURING SPECIFICATION:

Moisture content of powder should be less than 2.0 %.

Average weight of each Tablet is 210 milligrams.

Weight Variation Limit for average weight of 20 tablets is +5 %.

Friability limit for 20 Tablets is not more than 1.0 %.

Hardness of the Tablets varies between 2 – 4 kg/cm2.

Disintegration time for each Tablet is not more than 15 minutes.

Mix the batch, compress and de-dust the tablets and also perform the primary packing of Tablets at temperature not more than 25˚C.

Yield:

Theoretical Yield is 1.0 Lacs Tablets.

Expected Practical Yield is 1.0 Lacs + 2% Tablets.

PACKING DETAILS:

Use 104mm Transparent PVC and Aluminium foil for blister packing.

Blister Pack the inspected and De-dusted tablets by using Single Track Blister Packing Machine as per its SOP.

Put 1 strip each containing 30 tablets in each unit carton.

Shrink Pack 10 such cartons.

Pack such 39 shrink packets in a specified corrugated box  to give a final pack size of 39x10x1x30 tablets.

Seal the each corrugated box with adhesive tape and label it properly by affixing the specified label.

MANUFACTURING PROCESS:

Preparation of Starch Paste: Prepare the starch paste in the manner given below using Steam Jacketed Starch Paste Preparation Tank by   operating it as per its SOP.

Dissolve 0.030 kg of Sodium Benzoate in 1Litre of purified water and stir continuously.

Add 0.6kg of Starch in 1 Litre  purified  water and stir continuously to form a smooth slurry.

To this add the solution of sodium benzoate and starch slurry with constant stirring to get a uniform paste.

Sifting: Fit the Stainless Steel Sieve # 20 on the Sifter-I as per its SOP. Sift all the weighed ingredients through it and collect separately in Stainless Steel Container.

Blending: Blend the following ingredients in a Roto Cube Blender by operating it as per its SOP. for 15 minutes and collect the ingredients separately in stainless containers.

Di Calcium Phosphate

M.C.C.P.

Lactose

Starch

Wet Granulation:

Mix the above blended ingredients with the Starch paste using Rapid Mixer Granulator by operating it as per its SOP.

Add the starch paste in small proportions to the dry blend in a manner to achieve proper wetting.

Mix the blended powder and starch paste together in Rapid Mixer Granulator until the wet mass is ready for granulation.

Wet Screening: Pass the wet dough through a Multi Mill by operating it as per its SOP to convert the moist mass into coarse, granular aggregate.

Drying: Dry the granules in Fluidized Bed Drier by operating it as per its SOP at temperature 60˚ – 70˚ C for 30 minutes. Cool the granules to room temperature.

Sifting: Fit the Stainless Steel Sieve # 20 on the Sifter-II as per its SOP. Sift the granules through it and collect in Stainless Steel Container. Break the oversized granules left over the mesh in Oscillating Granulator by operating it as per its SOP and resift them.

Check the total weight of dried granules. Determine the loss on drying and percentage yield of dried granules.

Lubrication: Lubricate the sifted granules along the following ingredients in Roto Cube Blender by operating it as per its SOP for 30 minutes and collect in Stainless Steel Container.

4kg of Talcum

2kg of Magnesium Stearate

8kg of Starch

03kg of Aerosil

510kg of Norethisterone

IN-PROCESS CONTROLS:

The following in-process controls should be maintained during the processing:

Check Raw materials used for manufacturing purpose are all approved materials and have ‘Released’ labels fixed on it.

All weighed Raw materials should be counter-checked by  Manufacturing Chemist. If any discrepancy is noticed, it should be immediately brought to the notice of Production Pharmacist and QC/QA Manager.

Physical characteristics of Raw material like colour, odour, and consistency are checked before compounding.

Humidity and temperature should be maintained during the compression of thermolabile products.

Sample of dried granules should be sent to Quality Control Department for the determination of Moisture content.

The total weight of blended powder should be checked in the presence of Manufacturing Chemist and record the same in Batch Manufacturing Record.

Bulk sample should be sent for analysis to Quality Control Department before starting compression of tablets.

Weight Variation: Intermittently weight variation of compressed tablets should be checked at 30 minutes interval by the  Manufacturing Chemist and record for the same should be kept in Batch Manufacturing Record.

Out-of-limit tablets should be checked by Weight Variation Method as given below:

Take the average weight of 20 tablets on the calibrated balance and calculate the upper and lower limit as per the table given below in accordance with IP/BP:

AVERAGE WEIGHT OF TABLETS
                 (in mg)
  MAXIMUM PERCENTAGE DIFFERENCE                                                                      ALLOWED
80mg or less                                10
More than 80mg and less than 250mg                                 7.5
250mg or more                                  5

Take the weight of individual tablets and check if all the tablets are lying with in the limits.

Select the tablets only if no more than two tablets are out of percentage limit and if no tablet differs by more than two times the percentage limit, otherwise reject the tablets.

Adjust the desired weight of the tablets in the Compression Machine by moving weight adjustment cam clockwise or anticlockwise accordingly as per the MFR of Compression Machine.

Re-check the weight of tablets for further adjustment, if any.

Thickness of Tablets:  Thickness of the tablets should be determined by means of the vernier caliper. The thickness of the tablet should be checked whenever weight adjustments are made.

Hardness of the tablets: The equipment used is the ‘Monsanto’ type hardness tester. Hardness of the compressed tablets should be checked at regular interval to determine the need for pressure adjustments on the tableting machine.

Hardness of tablets varies between: 2-4 Kg/cm2.

Friability: ‘Roche Friabilator’ is used for measuring the Friability. The instrument is designed to evaluate the ability of the tablet to withstand abrasion in packaging, handling and shipping.

Adjust the instrument to 25 RPM before adding the tablets.

Weigh 20 Tablets on calibrated balance. Transfer the tablets in the plastic chamber. Close the drum tightly.

Switch on the apparatus. Operate the Friabilator for 100 revolutions.

De-dust and reweigh the tablets. Loss in weight indicates the ability of tablets to withstand the wear.

Take 10 tablets to check the friability, when the average weight of tablet is 1g or more than 1g.

Friability Limit  = Less than 1.0%

Disintegration Test: Disintegration is the time required for the group of tablets to disintegrate into the particles. Disintegration Test should be carried out at regular interval of 1 hour by using Disintegration Test Apparatus.

The tube assembly unit is removed from the glass beaker and from each tube the plastic discs are removed.

Place the tablets in each of 6 tubes along with a plastic disc over the tablets.

The glass beaker is filled with water. The water in the beaker is retained at the temperature of 37+1˚C through out the test by suitably setting the thermostat.

Introduce a tube assembly unit into glass beaker in such a way that wire mesh at the base of each tube is atleast 2.5cm below the surface of liquid when the basket is at highest position.

Switch on the apparatus to move the basket assembly containing the tablets up and down through a distance of 5 to 6 cm at a frequency of 28 to 32 cycles per minute. Start the stopwatch.

When the tablets have disintegrated i.e. when no particles remain on the wire mesh at the bottom of tube, stop the stopwatch. Note the time taken for disintegration of the tablets and record the same in Batch Manufacturing Record.

If one or two tablets fail to disintegrate, the test is to be repeated using 12 tablets.

Disintegration Time of uncoated tablets= Not more than 15 minutes

Disintegration Time of coated tablets= Not more than 30 minutes

Tablets taken for testing and In-process control should not be added to the bulk batch to avoid mix-ups and cross-contamination.

Inspection, sorting of rejected tablets should be done as per SOP.

The strips and cartons should be checked thoroughly for proper batch coding.

Manufacturing Chemist and Production Pharmacist should randomly check that the correct no. of strips are being packed in each cartons and also the number of cartons in each shipper is exactly the same as that shown in proof.

Intimation should be sent to Quality Control Department for finished product sampling and testing.

After the completion of labelling and packaging, the coded cartons should be accounted for and rejected printed material should be destroyed in the presence of QC/QA Manager. Fill the destruction sheet and attach the same in the Batch Manufacturing Record.

It will be ensure that filling or packaging equipment has been properly cleaned after the completion of batch.

Filling or packaging of next product should not commence until the IPQA has given the ‘Line Clearance’.

Glucosamine Sulphate